Ledger.Open graph →
SEC Form D · Amendment · filed May 2, 2018

MBF Therapeutics, Inc

Offering
$2.0M
Sold
$425K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AMBLER, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Chris M. Bunge · Ambler, PADirectorChristopher M. Cashman · Ambler, PADirectorThomas Tillett · Ambler, PAExec · DirectorJohn D. Rutledge · New York, NYExec · DirectorAndrew Pellett · Portsmouth, NHDirectorSherwin D. Jannat · New York, NYDirectorRakesh Narasimhan · Seattle, WADirectorMarian Joh · Seattle, WAExec · DirectorWilliam Christy · Bangor, MEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗